Product Wiki · Recalls · U.S. NHTSA

FORD ESCAPE (2020) — recall 25V693000

U.S. NHTSA · United States · 2025-10-10

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
U.S. NHTSA
Recall identifier
25V693000
Date of alert
2025-10-10
Country / jurisdiction
United States
Risk type
vehicle recall
Brand
Ford Motor Company
Product category
vehicle
Product type
SERVICE BRAKES, HYDRAULIC:FOUNDATION COMPONENTS:DISC:PADS
Model years
2020
Reported risk: Ford Motor Company (Ford) is recalling certain 2020 Escape vehicles. The rear brake pads may have been manufactured incorrectly, which can reduce brake function in the event of a brake booster malfunction. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 135, "Light Vehicle Brake Systems."
What you should do

Dealers will replace the front brake pads, free of charge. Owner notification letters were mailed on November 5, 2025. Owners may contact Ford customer service at 1-866-436-7332. Ford's number for this recall is 21C31. Vehicle Identification Numbers (VINs) involved in this recall became searchable on NHTSA.gov on October 13, 2025. This recall is an expansion of NHTSA recall number 21V922.

What can happen if it is not fixed

Reduced brake function can require the driver to apply more brake pedal force, and the distance required to stop the vehicle may be extended, increasing the risk of a crash.

Primary source: https://www.nhtsa.gov/recalls?nhtsaId=25V693000

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.